How will the two-weeks-wait rule affect delays in management of urological cancers?

Abstract

SUMMARYThe UK National Health Service has now specified a maximum interval of two weeks between general practitioner (GP) referral and specialist assessment for patients with suspected cancer. We examined progress through the cancer pathway in 160 patients with potentially curable cancers of the prostate, bladder, kidney and testis before implementation of this rule. Median intervals with interquartile ranges were quantified from the first GP consultation to hospital referral, then to the first hospital consultation, confirmation of diagnosis and definitive surgery.34% of patients were seen at the hospital within two weeks of referral. The overall median interval from GP consultation to radical surgery was 137 days, the longest being for prostate cancer (median 244). For prostate, bladder and renal cancers the principal element of delay was from the time of diagnosis to surgery (76, 73 and 26 days respectively).These results indicate that, under the two-weeks-wait rule, 2 out of every 3 patients achieve earlier initial assessment. However, the overall delay will not be substantially reduced without concomitant increases in diagnostic facilities, theatre time and human resources.

Prioritization of colorectal referrals: a review of the 2‐week wait referral system

“…There has been a decline in the breast cancer detection rate and an increase in the waiting time for patients not referred urgently by the GPs [36]. Patients with urological cancers continue to experience an overall significant delay in treatment in spite of the TWW rule [37].…”